Source: Tech – South China Morning Post[The content of this article has been produced by our advertising partner.]
Since their emergency-use rollout in late 2020, billions of doses of COVID 19 vaccines built on disruptive mRNA technology have been administered worldwide, saving hundreds of millions of lives. Now, the global pharmaceutical industry is pushing far beyond next generation vaccines. Companies worldwide are rapidly expanding into mRNA based therapeutics aimed at chronic and autoimmune diseases, rare genetic disorders,…Read More